McKesson EPS - Earnings per Share 2010-2024 | MCK

McKesson annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • McKesson EPS for the quarter ending March 31, 2024 was $6.03, a 5.98% increase year-over-year.
  • McKesson EPS for the twelve months ending March 31, 2024 was $22.39, a 10.55% decline year-over-year.
  • McKesson 2024 annual EPS was $22.39, a 10.55% decline from 2023.
  • McKesson 2023 annual EPS was $25.03, a 246.2% increase from 2022.
  • McKesson 2022 annual EPS was $7.23, a 125.58% decline from 2021.
McKesson Annual EPS
2024 $22.39
2023 $25.03
2022 $7.23
2021 $-28.26
2020 $4.95
2019 $0.17
2018 $0.32
2017 $22.73
2016 $9.70
2015 $6.27
2014 $5.41
2013 $5.59
2012 $5.59
2011 $4.57
2010 $4.62
2009 $2.95
McKesson Quarterly EPS
2024-03-31 $6.03
2023-12-31 $4.42
2023-09-30 $4.92
2023-06-30 $7.02
2023-03-31 $5.69
2022-12-31 $7.66
2022-09-30 $6.42
2022-06-30 $5.26
2022-03-31 $2.49
2021-12-31 $-0.04
2021-09-30 $1.71
2021-06-30 $3.07
2021-03-31 $4.51
2020-12-31 $-39.03
2020-09-30 $3.54
2020-06-30 $2.72
2020-03-31 $5.67
2019-12-31 $1.03
2019-09-30 $-3.99
2019-06-30 $2.24
2019-03-31 $-4.06
2018-12-31 $2.40
2018-09-30 $2.51
2018-06-30 $-0.68
2018-03-31 $-5.47
2017-12-31 $4.33
2017-09-30 $0.01
2017-06-30 $1.45
2017-03-31 $16.16
2016-12-31 $2.85
2016-09-30 $1.34
2016-06-30 $2.38
2016-03-31 $1.89
2015-12-31 $2.73
2015-09-30 $2.63
2015-06-30 $2.45
2015-03-31 $0.56
2014-12-31 $2.00
2014-09-30 $1.99
2014-06-30 $1.72
2014-03-31 $1.56
2013-12-31 $0.28
2013-09-30 $1.74
2013-06-30 $1.83
2013-03-31 $1.10
2012-12-31 $1.24
2012-09-30 $1.67
2012-06-30 $1.58
2012-03-31 $2.08
2011-12-31 $1.20
2011-09-30 $1.18
2011-06-30 $1.13
2011-03-31 $1.62
2010-12-31 $0.60
2010-09-30 $1.25
2010-06-30 $1.10
2010-03-31 $1.26
2009-12-31 $1.19
2009-09-30 $1.11
2009-06-30 $1.06
2009-03-31 $1.02
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $78.372B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.549B 19.11
Cardinal Health (CAH) United States $25.353B 14.50
West Pharmaceutical Services (WST) United States $23.461B 42.05
Cooper (COO) United States $18.251B 26.92
Align Technology (ALGN) United States $18.233B 35.20
Labcorp (LH) United States $17.408B 14.98
Henry Schein (HSIC) United States $8.743B 15.55
DENTSPLY SIRONA (XRAY) United States $5.328B 13.80
Merit Medical Systems (MMSI) United States $4.726B 25.90
Patterson (PDCO) United States $2.274B 10.99
CONMED (CNMD) United States $2.078B 18.85
STAAR Surgical (STAA) United States $2.026B 77.79
Atrion (ATRI) United States $0.803B 42.87
Lifevantage (LFVN) United States $0.085B 10.97
Pro-Dex (PDEX) United States $0.065B 32.67
Biolase (BIOL) United States $0.004B 0.00